Ventyx Market Capitalization from 2010 to 2025
| VTYX Stock | USD 2.25 0.06 2.60% |
Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 17.7 M, Depreciation And Amortization of 135.1 K or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.56. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.
Ventyx | Market Capitalization |
Latest Ventyx Biosciences' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Ventyx Biosciences over the last few years. It is Ventyx Biosciences' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ventyx Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 163.34 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Ventyx Market Capitalization Regression Statistics
| Arithmetic Mean | 1,161,713,710 | |
| Geometric Mean | 1,140,432,370 | |
| Coefficient Of Variation | 21.75 | |
| Mean Deviation | 188,047,377 | |
| Median | 1,057,232,556 | |
| Standard Deviation | 252,694,440 | |
| Sample Variance | 63854.5T | |
| Range | 753.3M | |
| R-Value | 0.50 | |
| Mean Square Error | 51570.4T | |
| R-Squared | 0.25 | |
| Significance | 0.05 | |
| Slope | 26,336,747 | |
| Total Sum of Squares | 957817.2T |
Ventyx Market Capitalization History
About Ventyx Biosciences Financial Statements
Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Ventyx Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.